ArticleThe oncologist2018

EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors.

Fernando Vargas-Madueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.